These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 18638924)

  • 21. Intraventricular administration of hepatocyte growth factor treats mouse communicating hydrocephalus induced by transforming growth factor beta1.
    Tada T; Zhan H; Tanaka Y; Hongo K; Matsumoto K; Nakamura T
    Neurobiol Dis; 2006 Mar; 21(3):576-86. PubMed ID: 16352434
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Subacute hydrocephalus after experimental subarachnoid hemorrhage: its prevention by intrathecal fibrinolysis with recombinant tissue plasminogen activator.
    Brinker T; Seifert V; Dietz H
    Neurosurgery; 1992 Aug; 31(2):306-11; discussion 311-2. PubMed ID: 1513435
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cannabinoid receptor 2 activation restricts fibrosis and alleviates hydrocephalus after intraventricular hemorrhage.
    Tan Q; Chen Q; Feng Z; Shi X; Tang J; Tao Y; Jiang B; Tan L; Feng H; Zhu G; Yang Y; Chen Z
    Brain Res; 2017 Jan; 1654(Pt A):24-33. PubMed ID: 27769788
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Local injection of latency-associated peptide, a linker propeptide specific for active form of transforming growth factor-beta1, inhibits dermal sclerosis in bleomycin-induced murine scleroderma.
    Nakamura-Wakatsuki T; Oyama N; Yamamoto T
    Exp Dermatol; 2012 Mar; 21(3):189-94. PubMed ID: 22188586
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disturbed spatial learning of rats after intraventricular administration of transforming growth factor-beta 1.
    Nakazato F; Tada T; Sekiguchi Y; Murakami K; Yanagisawa S; Tanaka Y; Hongo K
    Neurol Med Chir (Tokyo); 2002 Apr; 42(4):151-6; discussion 157. PubMed ID: 12013666
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Using adenovirus armed short hairpin RNA targeting transforming growth factor β1 inhibits melanoma growth and metastasis in an ex vivo animal model.
    Tai KF; Wang CH
    Ann Plast Surg; 2013 Dec; 71 Suppl 1():S75-81. PubMed ID: 24284745
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intrathecal lactate predicting hydrocephalus after aneurysmal subarachnoid hemorrhage.
    Wang KC; Tang SC; Lee JE; Jeng JS; Lai DM; Huang SJ; Hsieh ST; Tu YK
    J Surg Res; 2015 Dec; 199(2):523-8. PubMed ID: 26076684
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ultrastructural analysis of a murine model of congenital hydrocephalus produced by overexpression of transforming growth factor-beta1 in the central nervous system.
    Aliev G; Miller JP; Leifer DW; Obrenovich ME; Shenk JC; Smith MA; Lamanna JC; Perry G; Lust DW; Cohen AR
    J Submicrosc Cytol Pathol; 2006; 38(2-3):85-91. PubMed ID: 17784635
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Soluble endoglin and transforming growth factor-β₁ and the development of vasospasm after spontaneous subarachnoid hemorrhage: a pilot study.
    Dietmann A; Lackner P; Fischer M; Broessner G; Pfausler B; Helbok R; Schmutzhard E; Beer R
    Cerebrovasc Dis; 2012; 33(1):16-22. PubMed ID: 22133666
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Soluble Epoxide Hydrolase in Hydrocephalus, Cerebral Edema, and Vascular Inflammation After Subarachnoid Hemorrhage.
    Siler DA; Berlow YA; Kukino A; Davis CM; Nelson JW; Grafe MR; Ono H; Cetas JS; Pike M; Alkayed NJ
    Stroke; 2015 Jul; 46(7):1916-22. PubMed ID: 25991416
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chronologic changes of cerebral ventricular size in a transgenic model of hydrocephalus.
    Hayashi N; Leifer DW; Cohen AR
    Pediatr Neurosurg; 2000 Oct; 33(4):182-7. PubMed ID: 11124634
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TGF-beta1 expression is reduced in hydrocephalic H-Tx rat brain.
    Cai X; Pattisapu JV; Tarnuzzer RW; Fernandez-Valle C; Gibson JS
    Eur J Pediatr Surg; 1999 Dec; 9 Suppl 1():35-8. PubMed ID: 10661791
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heavy water inhibiting the expression of transforming growth factor-beta1 and the development of kaolin-induced hydrocephalus in mice.
    Hatta J; Hatta T; Moritake K; Otani H
    J Neurosurg; 2006 Apr; 104(4 Suppl):251-8. PubMed ID: 16619636
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protection of TGF-β1 against neuroinflammation and neurodegeneration in Aβ1-42-induced Alzheimer's disease model rats.
    Chen JH; Ke KF; Lu JH; Qiu YH; Peng YP
    PLoS One; 2015; 10(2):e0116549. PubMed ID: 25658940
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adenoviral supply of active transforming growth factor-beta1 (TGF-beta1) did not prevent lethality in transforming growth factor-beta1-knockout embryos.
    Chagraoui H; Giraudier S; Vainchenker W; Wendling F
    Eur Cytokine Netw; 2001; 12(4):561-7. PubMed ID: 11781182
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preventive effects of cilostazol against the development of shunt-dependent hydrocephalus after subarachnoid hemorrhage.
    Nakatsuka Y; Kawakita F; Yasuda R; Umeda Y; Toma N; Sakaida H; Suzuki H;
    J Neurosurg; 2017 Aug; 127(2):319-326. PubMed ID: 27494819
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Involvement of TGF-β1/Smad3 Signaling in Carbon Tetrachloride-Induced Acute Liver Injury in Mice.
    Niu L; Cui X; Qi Y; Xie D; Wu Q; Chen X; Ge J; Liu Z
    PLoS One; 2016; 11(5):e0156090. PubMed ID: 27224286
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The first stage of transforming growth factor beta1 activation is release of the large latent complex from the extracellular matrix of growth plate chondrocytes by matrix vesicle stromelysin-1 (MMP-3).
    Maeda S; Dean DD; Gomez R; Schwartz Z; Boyan BD
    Calcif Tissue Int; 2002 Jan; 70(1):54-65. PubMed ID: 11907708
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bone substitutes as carriers for transforming growth factor-beta(1) (TGF-beta(1)).
    Gille J; Dorn B; Kekow J; Bruns J; Behrens P
    Int Orthop; 2002; 26(4):203-6. PubMed ID: 12185519
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Defective processing of the transforming growth factor-beta1 in azoxymethane-induced mouse colon tumors.
    Guda K; Claffey KP; Dong M; Nambiar PR; Rosenberg DW
    Mol Carcinog; 2003 May; 37(1):51-9. PubMed ID: 12720300
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.